Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Gina Kruse

Concepts (245)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Smoking Cessation
18
2025
436
6.680
 Why?
Early Detection of Cancer
9
2026
472
2.740
 Why?
Text Messaging
5
2023
183
2.240
 Why?
Tobacco Use
4
2026
62
1.930
 Why?
Tobacco Use Cessation
3
2025
28
1.790
 Why?
Smoking
9
2026
1467
1.790
 Why?
Electronic Nicotine Delivery Systems
7
2026
108
1.290
 Why?
Primary Health Care
7
2023
1730
1.240
 Why?
Massachusetts
9
2026
180
1.180
 Why?
HIV Infections
9
2026
3148
1.050
 Why?
Smokers
4
2020
137
1.000
 Why?
Varenicline
2
2025
28
0.960
 Why?
Tobacco Products
3
2025
84
0.950
 Why?
Uterine Cervical Neoplasms
3
2025
269
0.950
 Why?
Colorectal Neoplasms
4
2025
849
0.930
 Why?
Tobacco Use Disorder
3
2022
218
0.910
 Why?
Behavior Therapy
3
2025
300
0.900
 Why?
Opioid-Related Disorders
4
2026
601
0.890
 Why?
Intention
1
2026
187
0.820
 Why?
Postal Service
2
2020
27
0.790
 Why?
Buprenorphine
2
2025
190
0.790
 Why?
Peer Group
1
2026
256
0.780
 Why?
Laboratories
1
2023
110
0.710
 Why?
Lung Neoplasms
2
2026
2660
0.710
 Why?
Community Health Services
2
2015
231
0.710
 Why?
Social Support
1
2026
650
0.690
 Why?
United States Indian Health Service
2
2022
45
0.660
 Why?
India
4
2026
220
0.650
 Why?
Humans
66
2026
144671
0.640
 Why?
Alaska Natives
1
2022
101
0.640
 Why?
Patient Discharge
3
2024
985
0.630
 Why?
Health Knowledge, Attitudes, Practice
3
2026
1406
0.630
 Why?
Mentoring
1
2023
164
0.610
 Why?
Middle Aged
28
2026
35971
0.590
 Why?
Electronic Health Records
4
2016
1176
0.590
 Why?
Adult
33
2026
40489
0.570
 Why?
Papillomavirus Infections
1
2023
342
0.560
 Why?
Cross-Sectional Studies
13
2026
5870
0.550
 Why?
Health Behavior
3
2022
786
0.550
 Why?
Female
41
2026
78304
0.540
 Why?
Delivery of Health Care
4
2023
944
0.540
 Why?
Community Health Centers
5
2025
59
0.530
 Why?
Male
36
2026
72431
0.520
 Why?
Pilot Projects
6
2025
1886
0.510
 Why?
Telemedicine
3
2025
957
0.510
 Why?
Hospitalization
4
2025
2446
0.510
 Why?
Indians, North American
1
2022
597
0.490
 Why?
Meaningful Use
1
2016
13
0.490
 Why?
Rural Population
3
2024
657
0.480
 Why?
Commerce
2
2026
80
0.450
 Why?
Comorbidity
2
2017
1652
0.440
 Why?
Motivation
2
2019
601
0.440
 Why?
Smoke-Free Policy
1
2014
13
0.430
 Why?
Smoking Prevention
1
2015
166
0.420
 Why?
Unnecessary Procedures
1
2014
54
0.410
 Why?
Tobacco Smoking
2
2024
26
0.390
 Why?
Opiate Substitution Treatment
3
2025
186
0.390
 Why?
Reimbursement, Incentive
1
2013
42
0.380
 Why?
Program Development
1
2015
368
0.380
 Why?
Counseling
4
2024
405
0.380
 Why?
Vaping
2
2025
66
0.370
 Why?
United States
13
2026
16018
0.370
 Why?
Tobacco Smoke Pollution
1
2014
227
0.360
 Why?
Colonoscopy
1
2014
260
0.350
 Why?
Health Equity
3
2024
132
0.340
 Why?
Telephone
2
2023
176
0.340
 Why?
Documentation
1
2013
198
0.340
 Why?
Population Surveillance
1
2014
484
0.330
 Why?
Aged
15
2026
25955
0.320
 Why?
Neoplasms
2
2023
2873
0.320
 Why?
Prevalence
5
2026
2839
0.290
 Why?
Boston
4
2026
92
0.290
 Why?
Anti-HIV Agents
2
2014
890
0.290
 Why?
Alcoholism
2
2025
813
0.280
 Why?
Qualitative Research
4
2026
1668
0.270
 Why?
Referral and Consultation
2
2012
852
0.270
 Why?
Randomized Controlled Trials as Topic
3
2025
1742
0.270
 Why?
Students
2
2022
657
0.240
 Why?
Tobacco, Smokeless
1
2026
13
0.240
 Why?
Oklahoma
1
2026
21
0.240
 Why?
Cotinine
1
2026
76
0.230
 Why?
Flavoring Agents
1
2025
11
0.230
 Why?
Alcohol Deterrents
1
2025
26
0.230
 Why?
South Africa
2
2024
265
0.220
 Why?
Appointments and Schedules
2
2002
96
0.210
 Why?
Feasibility Studies
2
2022
1103
0.210
 Why?
Pandemics
3
2021
1700
0.200
 Why?
Occult Blood
1
2024
39
0.200
 Why?
Faculty
2
2022
153
0.200
 Why?
Patient Compliance
2
2012
587
0.200
 Why?
Outpatients
2
2024
447
0.200
 Why?
Substance Withdrawal Syndrome
1
2025
187
0.190
 Why?
Mental Disorders
2
2002
1154
0.190
 Why?
Social Determinants of Health
2
2024
305
0.190
 Why?
Health Policy
1
2026
398
0.190
 Why?
Vaginal Smears
1
2023
54
0.190
 Why?
Cost-Benefit Analysis
1
2025
638
0.190
 Why?
Narcotic Antagonists
1
2025
204
0.190
 Why?
Safety-net Providers
1
2024
128
0.180
 Why?
Papillomaviridae
1
2023
114
0.180
 Why?
Cooperative Behavior
1
2025
464
0.180
 Why?
Outpatient Clinics, Hospital
1
2002
80
0.180
 Why?
Interrupted Time Series Analysis
1
2022
75
0.180
 Why?
Treatment Refusal
1
2002
98
0.180
 Why?
Medically Underserved Area
1
2022
100
0.180
 Why?
Student Run Clinic
1
2021
3
0.170
 Why?
Internet
1
2026
698
0.170
 Why?
Tuberculosis
1
2024
291
0.170
 Why?
Mass Screening
3
2025
1348
0.170
 Why?
Patient Participation
1
2005
428
0.170
 Why?
Pain Management
1
2005
410
0.160
 Why?
Medication Adherence
1
2025
540
0.160
 Why?
Education, Medical, Undergraduate
1
2023
205
0.150
 Why?
Developing Countries
2
2015
317
0.150
 Why?
Community Networks
1
2020
57
0.150
 Why?
Physician-Patient Relations
1
2005
589
0.150
 Why?
Longitudinal Studies
2
2020
2942
0.150
 Why?
Education, Medical
1
2023
273
0.150
 Why?
Ambulatory Care
1
2024
607
0.150
 Why?
Interviews as Topic
3
2019
905
0.150
 Why?
Young Adult
7
2025
14122
0.150
 Why?
Crisis Intervention
1
2019
37
0.150
 Why?
Pain
1
2005
785
0.150
 Why?
Preventive Health Services
1
2020
154
0.140
 Why?
Analgesics, Opioid
2
2024
1142
0.140
 Why?
Nevirapine
2
2008
18
0.140
 Why?
Cohort Studies
5
2025
5957
0.130
 Why?
Students, Medical
1
2023
374
0.130
 Why?
Organophosphonates
2
2008
97
0.130
 Why?
Decision Making
1
2005
973
0.130
 Why?
Surveys and Questionnaires
4
2019
6041
0.130
 Why?
Liver Transplantation
1
2024
826
0.120
 Why?
Deoxycytidine
2
2008
222
0.120
 Why?
Adolescent
8
2025
22409
0.120
 Why?
Licensure
2
2026
16
0.120
 Why?
Communication
1
2023
972
0.120
 Why?
Pneumonia, Viral
1
2021
387
0.120
 Why?
Infectious Disease Transmission, Vertical
2
2008
193
0.120
 Why?
Texas
4
2005
271
0.120
 Why?
Diabetes Mellitus
1
2024
1076
0.120
 Why?
Hypertension
1
2024
1262
0.120
 Why?
Diffusion of Innovation
1
2016
95
0.120
 Why?
Adenine
2
2008
337
0.110
 Why?
Focus Groups
2
2022
566
0.110
 Why?
Tomography, X-Ray Computed
1
2026
2754
0.110
 Why?
Allied Health Personnel
1
2015
55
0.110
 Why?
Caregivers
1
2024
1062
0.110
 Why?
Health Surveys
1
2017
517
0.110
 Why?
Automobiles
1
2014
18
0.110
 Why?
Logistic Models
3
2017
2114
0.100
 Why?
Uganda
1
2014
92
0.100
 Why?
Community Health Workers
1
2015
86
0.100
 Why?
Colonic Polyps
1
2014
85
0.100
 Why?
Odds Ratio
3
2008
1076
0.100
 Why?
Program Evaluation
2
2020
941
0.100
 Why?
Residence Characteristics
2
2014
374
0.100
 Why?
Research Design
1
2019
1129
0.090
 Why?
Managed Care Programs
1
2013
140
0.090
 Why?
Patient Admission
1
2014
220
0.090
 Why?
Hospitals, Psychiatric
2
2002
27
0.090
 Why?
Stress, Psychological
1
2021
1148
0.090
 Why?
Social Class
1
2014
265
0.090
 Why?
Nurses
1
2014
168
0.090
 Why?
Prospective Studies
3
2025
7994
0.090
 Why?
HIV-1
2
2008
897
0.090
 Why?
Patient Acceptance of Health Care
3
2022
881
0.090
 Why?
Feedback
1
2012
181
0.090
 Why?
Health Services Accessibility
4
2024
1098
0.090
 Why?
Health Plan Implementation
1
2012
141
0.080
 Why?
Quality Assurance, Health Care
1
2013
341
0.080
 Why?
Retrospective Studies
5
2025
17149
0.080
 Why?
Follow-Up Studies
2
2024
5414
0.080
 Why?
Emergency Service, Hospital
1
2022
2325
0.080
 Why?
Hospitals
1
2014
729
0.070
 Why?
Diabetes Mellitus, Type 2
1
2022
2573
0.070
 Why?
Reverse Transcriptase Inhibitors
1
2007
87
0.060
 Why?
Chronic Disease
1
2013
1810
0.060
 Why?
Drug Resistance, Viral
1
2007
123
0.060
 Why?
Taxes
1
2026
16
0.060
 Why?
Patient Care Team
1
2012
690
0.060
 Why?
Renal Insufficiency
1
2008
172
0.060
 Why?
Anti-Retroviral Agents
1
2008
250
0.060
 Why?
Behavioral Risk Factor Surveillance System
1
2025
57
0.060
 Why?
Risk Factors
2
2014
10796
0.060
 Why?
Regression Analysis
2
2005
998
0.060
 Why?
Aged, 80 and over
4
2024
8284
0.050
 Why?
Insurance, Health
2
2005
308
0.050
 Why?
Naltrexone
1
2025
118
0.050
 Why?
Insurance Coverage
2
2022
243
0.050
 Why?
Vaccination
2
2022
1419
0.050
 Why?
Drug Therapy, Combination
2
2022
1044
0.050
 Why?
Pregnancy Complications, Infectious
1
2008
431
0.050
 Why?
Quality Improvement
1
2012
1287
0.050
 Why?
Housing
1
2024
147
0.050
 Why?
Social Networking
1
2023
37
0.050
 Why?
Mobile Health Units
1
2022
20
0.050
 Why?
Rural Health Services
1
2004
139
0.050
 Why?
Midwestern United States
1
2002
45
0.050
 Why?
Health Services for the Aged
1
2003
71
0.050
 Why?
Pragmatic Clinical Trials as Topic
1
2022
133
0.040
 Why?
Health Status
2
2005
834
0.040
 Why?
Hospitals, University
1
2002
176
0.040
 Why?
Bupropion
1
2022
47
0.040
 Why?
Stakeholder Participation
1
2022
83
0.040
 Why?
Antiviral Agents
1
2007
765
0.040
 Why?
Schools, Medical
1
2023
158
0.040
 Why?
Meals
1
2022
128
0.040
 Why?
Quality of Life
2
2022
3183
0.040
 Why?
Continuity of Patient Care
1
2004
293
0.040
 Why?
England
1
2021
108
0.040
 Why?
Vulnerable Populations
1
2022
175
0.040
 Why?
HIV
1
2022
248
0.040
 Why?
Data Collection
1
2024
635
0.040
 Why?
Hospital Mortality
1
2025
1033
0.040
 Why?
Minority Groups
1
2022
283
0.040
 Why?
Poverty
1
2024
522
0.040
 Why?
Length of Stay
1
2025
1339
0.040
 Why?
Urban Population
1
2003
493
0.040
 Why?
Triage
1
2021
249
0.040
 Why?
Age Factors
1
2026
3329
0.030
 Why?
Learning
1
2023
448
0.030
 Why?
Medicaid
1
2003
464
0.030
 Why?
Zambia
2
2008
58
0.030
 Why?
Treatment Outcome
1
2012
11735
0.030
 Why?
Medicare
1
2003
899
0.030
 Why?
Practice Guidelines as Topic
1
2025
1569
0.030
 Why?
Emtricitabine
2
2008
205
0.030
 Why?
Tenofovir
2
2008
295
0.030
 Why?
Curriculum
1
2023
1063
0.030
 Why?
Child
2
2024
22600
0.020
 Why?
Case-Control Studies
1
2017
3603
0.020
 Why?
Socioeconomic Factors
2
2004
1322
0.020
 Why?
Chi-Square Distribution
1
2008
524
0.020
 Why?
Antiretroviral Therapy, Highly Active
1
2008
278
0.020
 Why?
Creatinine
1
2008
509
0.020
 Why?
Risk
1
2008
911
0.010
 Why?
Proportional Hazards Models
1
2008
1322
0.010
 Why?
Pregnancy
2
2008
7122
0.010
 Why?
Glomerular Filtration Rate
1
2008
764
0.010
 Why?
Health Status Indicators
1
2004
167
0.010
 Why?
Office Visits
1
2003
92
0.010
 Why?
Health Care Surveys
1
2003
537
0.010
 Why?
Disease Progression
1
2008
2847
0.010
 Why?
Biomarkers
1
2008
4261
0.010
 Why?
Infant, Newborn
1
2007
6399
0.010
 Why?
Kruse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (245) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)